Search research articles
Contact Us
Filters
Showing results (381-390 of 410) with videos related to
Page
of 41
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN
|
February 23, 2021
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis
Meg Jardine, Zien Zhou, Hiddo J Lambers Heerspink, et al.
Journal of Cardiac Failure
|
September 19, 2024
Integration of Patient Reported Quality-of-life Data into Risk Assessment in Heart Failure
Konstantinos Sideris, Mingyuan Zhang, Peter Wohlfahrt, et al.
Heart Rhythm
|
September 8, 2024
Lesion delivery and scar formation in catheter ablation for atrial fibrillation: The DECAAF II trial
Nazem Akoum, Mario Mekhael, Felipe Bisbal, et al.
Journal of the American Society of Nephrology : JASN
|
May 2, 2020
Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial
Meg J Jardine, Zien Zhou, Kenneth W Mahaffey, et al.
Journal of Medical Internet Research
|
July 28, 2025
Population-Based Digital Health Interventions to Deliver at-Home COVID-19 Testing: SCALE-UP II Randomized Clinical Trial
Guilherme Del Fiol, Tatyana V Kuzmenko, Brian Orleans, et al.
BMC Nephrology
|
February 25, 2021
Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes
Srinivasan Beddhu, Robert E Boucher, Jie Sun, et al.
The New England Journal of Medicine
|
April 17, 2019
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg J Jardine, Bruce Neal, et al.
Journal of the American Society of Nephrology : JASN
|
April 20, 2019
The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration
Laura M Dember, Eduardo Lacson, Steven M Brunelli, et al.
Circulation
|
July 12, 2019
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups
Kenneth W Mahaffey, Meg J Jardine, Severine Bompoint, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
November 13, 2012
Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS
Ronald J Hogg, Aaron Friedman, Tom Greene, et al.
Page
of 41
Search research articles
Search
Showing results (381-390 of 410) with videos related to
Sort By:
Page
of 41
Clinical Journal of the American Society of Nephrology : CJASN
|
February 23, 2021
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis
Meg Jardine, Zien Zhou, Hiddo J Lambers Heerspink, et al.
Journal of Cardiac Failure
|
September 19, 2024
Integration of Patient Reported Quality-of-life Data into Risk Assessment in Heart Failure
Konstantinos Sideris, Mingyuan Zhang, Peter Wohlfahrt, et al.
Heart Rhythm
|
September 8, 2024
Lesion delivery and scar formation in catheter ablation for atrial fibrillation: The DECAAF II trial
Nazem Akoum, Mario Mekhael, Felipe Bisbal, et al.
Journal of the American Society of Nephrology : JASN
|
May 2, 2020
Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial
Meg J Jardine, Zien Zhou, Kenneth W Mahaffey, et al.
Journal of Medical Internet Research
|
July 28, 2025
Population-Based Digital Health Interventions to Deliver at-Home COVID-19 Testing: SCALE-UP II Randomized Clinical Trial
Guilherme Del Fiol, Tatyana V Kuzmenko, Brian Orleans, et al.
BMC Nephrology
|
February 25, 2021
Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes
Srinivasan Beddhu, Robert E Boucher, Jie Sun, et al.
The New England Journal of Medicine
|
April 17, 2019
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg J Jardine, Bruce Neal, et al.
Journal of the American Society of Nephrology : JASN
|
April 20, 2019
The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration
Laura M Dember, Eduardo Lacson, Steven M Brunelli, et al.
Circulation
|
July 12, 2019
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups
Kenneth W Mahaffey, Meg J Jardine, Severine Bompoint, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
November 13, 2012
Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS
Ronald J Hogg, Aaron Friedman, Tom Greene, et al.
Page
of 41